{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:42:23Z","timestamp":1790934143946,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Trace Elements in Medicine and Biology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jtemb.2010.01.006","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T09:48:41Z","timestamp":1265104121000},"page":"69-77","source":"Crossref","is-referenced-by-count":75,"title":["Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs"],"prefix":"10.1016","volume":"24","author":[{"given":"Bernhard","family":"Michalke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtemb.2010.01.006_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenberg","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jtemb.2010.01.006_bib2","first-page":"3","article-title":"The start platinum complexes for the treatment of cancer: why the search goes on","volume":"vol. 4","author":"Rosenberg","year":"1999"},{"key":"10.1016\/j.jtemb.2010.01.006_bib3","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1021\/cr980420v","article-title":"Current status of platinum-based anti-tumor drugs","volume":"99","author":"Wong","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtemb.2010.01.006_bib4","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612033454180","article-title":"Recent developments in the field of tumor-inhibiting metal complexes","volume":"9","author":"Galanski","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jtemb.2010.01.006_bib5","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s00216-007-1147-9","article-title":"A study of the interactions between carboplatin and blood plasma proteins using size exclusion chromatography coupled to inductively coupled plasma mass spectrometry","volume":"387","author":"Xie","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib6","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/cr040704h","article-title":"Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology","volume":"106","author":"Timerbaev","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtemb.2010.01.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-002-0001-x","article-title":"Tumour-inhibiting platinum complexes \u2013 state of the art and future perspectives","volume":"146","author":"Jakupec","year":"2003","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.jtemb.2010.01.006_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/13543784.10.1.119","article-title":"Lobaplatin: a new antitumour platinum drug","volume":"10","author":"McKeage","year":"2001","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.jtemb.2010.01.006_bib9","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/(SICI)1521-3773(19990601)38:11<1512::AID-ANIE1512>3.0.CO;2-Y","article-title":"Metals in medicine","volume":"38","author":"Guo","year":"1999","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.jtemb.2010.01.006_bib11","doi-asserted-by":"crossref","first-page":"12309","DOI":"10.1021\/ja9625079","article-title":"Crystal structure of the anticancer drug cisplatin bound to duplex DNA","volume":"118","author":"Takahara","year":"1996","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jtemb.2010.01.006_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/377649a0","article-title":"Crystal-structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin","volume":"377","author":"Takahara","year":"1995","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.jtemb.2010.01.006_bib13","doi-asserted-by":"crossref","first-page":"49743","DOI":"10.1074\/jbc.M206979200","article-title":"2.4-A crystal structure of the asymmetric platinum complex {Pt(ammine)(cyclohexylamine)}(2+) bound to a dodecamer DNA complex","volume":"277","author":"Silverman","year":"2002","journal-title":"J Biol Chem"},{"issue":"26","key":"10.1016\/j.jtemb.2010.01.006_bib14","doi-asserted-by":"crossref","first-page":"9230","DOI":"10.1021\/bi973176v","article-title":"NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin","volume":"37","author":"Gelasco","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtemb.2010.01.006_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/B711922D","article-title":"Atomic (HPLC\u2013ICP-MS) and molecular mass spectrometry (ESI-Q-TOF) to study cis-platin interactions with serum proteins","volume":"23","author":"Esteban-Fernandez","year":"2008","journal-title":"J Anal Atom Spectrom"},{"key":"10.1016\/j.jtemb.2010.01.006_bib16","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1073\/pnas.0737293100","article-title":"New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA","volume":"100","author":"Reedijk","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jtemb.2010.01.006_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1367-5931(99)80037-4","article-title":"Medicinal applications of heavy-metal compounds","volume":"3","author":"Reedijk","year":"1999","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jtemb.2010.01.006_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0898-8838(08)60271-8","article-title":"Medicinal inorganic chemistry","volume":"49","author":"Guo","year":"2000","journal-title":"Adv Inorg Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-8545(97)00047-7","article-title":"Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules","volume":"166","author":"Appleton","year":"1997","journal-title":"Coord Chem Rev"},{"issue":"1","key":"10.1016\/j.jtemb.2010.01.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/MBD.1996.15","article-title":"Comparison of the antiproliferative activity of two antitumour ruthenium(III) complexes with their apotransferrin and transferrin-bound forms in a human colon cancer cell line","volume":"3","author":"Kratz","year":"1996","journal-title":"Met Based Drugs"},{"key":"10.1016\/j.jtemb.2010.01.006_bib21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1039\/B309028K","article-title":"Application of HPLC\u2013ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine","volume":"18","author":"Hann","year":"2003","journal-title":"J Anal Atom Spectrom"},{"key":"10.1016\/j.jtemb.2010.01.006_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0378-4347(00)00498-9","article-title":"Speciation of platinum compounds: a review of recent applications in studies of platinum anticancer drugs","volume":"751","author":"Barefoot","year":"2001","journal-title":"J Chromatogr B"},{"issue":"7","key":"10.1016\/j.jtemb.2010.01.006_bib23","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1039\/b716093c","article-title":"Hydrophilic interaction liquid chromatography (HILIC) coupled to inductively coupled plasma mass spectrometry (ICP-MS) utilizing a mobile phase with a low-volatile organic modifier for determination of cisplatin, and its monohydrolyzed metabolite","volume":"23","author":"Nygren","year":"2008","journal-title":"J Anal Atom Spectrom"},{"key":"10.1016\/j.jtemb.2010.01.006_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0021-9673(95)00920-5","article-title":"Separation of platinum(II) anti-tumour drugs by micellar electrokinetic capillary chromatography","volume":"724","author":"Wenclawiak","year":"1996","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jtemb.2010.01.006_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0021-9673(01)01489-3","article-title":"Capillary electrophoresis of platinum group elements \u2013 analytical speciation and biochemical studies","volume":"945","author":"Timerbaev","year":"2002","journal-title":"J Chomatogr A"},{"issue":"6","key":"10.1016\/j.jtemb.2010.01.006_bib26","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00775-005-0013-5","article-title":"Effects of geometric isomerism in dinuclear platinum antitumor complexes on aquation reactions in the presence of perchlorate, acetate and phosphate","volume":"10","author":"Zhang","year":"2005","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib27","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1039\/b907011g","article-title":"Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP\u2013SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection","volume":"24","author":"Falta","year":"2009","journal-title":"J Anal Atom Spectrom"},{"issue":"12","key":"10.1016\/j.jtemb.2010.01.006_bib28","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1248\/bpb.17.1561","article-title":"Binding and aggregation of human gamma-globulin by cis-diamminedichloroplatinum(II) through disulfide bond","volume":"17","author":"Chen","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jtemb.2010.01.006_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0162-0134(99)00183-X","article-title":"Effect of cis-, trans-diamminedichloro-platinum(II) and DBP on human serum albumin","volume":"77","author":"Trynda-Lemiesz","year":"1999","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib30","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1248\/cpb.39.3003","article-title":"Multiple and irreversible binding of cis-diamminedichloroplatinum(ii) to human serum-albumin and its effect on warfarin-binding","volume":"39","author":"Yotsuyanagi","year":"1991","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.jtemb.2010.01.006_bib31","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/elps.200305984","article-title":"Platinum metallodrug\u2013protein binding studies by capillary electrophoresis-inductively couped plasma mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin","volume":"25","author":"Timerbaev","year":"2004","journal-title":"Electrophoresis"},{"issue":"2","key":"10.1016\/j.jtemb.2010.01.006_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0165-9936(01)00146-7","article-title":"The coupling of LC to ICP-MS in element speciation: 1. General aspects","volume":"21","author":"Michalke","year":"2002","journal-title":"Trends Anal Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib33","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1074\/jbc.273.24.14721","article-title":"Cisplatin binding sites on human albumin","volume":"273","author":"Ivanov","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s007750050386","article-title":"Identification of platination sites on human serum transferrin using C-13 and N-15 NMR spectroscopy","volume":"4","author":"Cox","year":"1999","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib35","doi-asserted-by":"crossref","unstructured":"Heudi O, Mercier-Jobard S, Cailleux A, Allan P. Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin. Biopharm Drug Dispos 1999;20:107\u201316.","DOI":"10.1002\/(SICI)1099-081X(199903)20:2<107::AID-BDD161>3.0.CO;2-0"},{"key":"10.1016\/j.jtemb.2010.01.006_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0378-4347(98)00565-9","article-title":"High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin","volume":"724","author":"Luo","year":"1999","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.jtemb.2010.01.006_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0021-9673(99)00467-7","article-title":"Capillary electrophoretic study of cisplatin interaction with nucleoside monophosphates, di- and trinucleotides","volume":"852","author":"Zenker","year":"1999","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jtemb.2010.01.006_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-4347(00)00096-7","article-title":"Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis","volume":"745","author":"Zenker","year":"2000","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.jtemb.2010.01.006_bib39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s007750050010","article-title":"Time-dependent interactions of platinum(II) complexes with 5'-GMP under simulated physiological conditions studied by capillary electrophoresis","volume":"5","author":"Zenker","year":"2000","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0162-0134(00)00182-3","article-title":"Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides","volume":"83","author":"K\u00fcng","year":"2001","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1522-2683(200101)22:1<97::AID-ELPS97>3.0.CO;2-Y","article-title":"Separation and identification of platinum adducts with DNA nucleotides by capillary zone electrophoresis and capillary zone electrophoresis coupled to mass spectrometry","volume":"22","author":"Warnke","year":"2001","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jtemb.2010.01.006_bib42","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/cr980422f","article-title":"Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?","volume":"99","author":"Reedijk","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.jtemb.2010.01.006_bib43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1039\/B603434A","article-title":"Speciation studies of cis-platin adducts with DNA nucleotides via elemental specific detection (P and Pt) using liquid chromatography\u2013inductively coupled plasma mass spectrometry and structural characterization by electrospray mass spectrometry","volume":"21","author":"Sar","year":"2006","journal-title":"J Anal Atom Spectrom"},{"issue":"9","key":"10.1016\/j.jtemb.2010.01.006_bib44","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1517\/17425255.4.9.1187","article-title":"The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies","volume":"4","author":"Gammelgaard","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.jtemb.2010.01.006_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002160100740","article-title":"HPLC-UV\u2013ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate","volume":"370","author":"Hann","year":"2001","journal-title":"Fresenius J Anal Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib46","series-title":"Cisplatin chemistry and biochemistry of a leading anticancer drug","author":"Lippart","year":"1999"},{"key":"10.1016\/j.jtemb.2010.01.006_bib47","series-title":"Cisplatin: chemistry and biochemistry of a leading anticancer drug","first-page":"31","article-title":"Clinical status of cisplatin, carboplatin and other platinum based antitumor drugs","author":"O'Dwyer","year":"1999"},{"key":"10.1016\/j.jtemb.2010.01.006_bib48","series-title":"Platinum-based drugs in cancer therapy","first-page":"251","article-title":"Clinical toxicology of platinum-based cancer chemotherapeutic agents","author":"McKeage","year":"2000"},{"key":"10.1016\/j.jtemb.2010.01.006_bib49","first-page":"S14","article-title":"Pharmacokinetic properties of platinium derivatives","volume":"88","author":"Biosdron-Celle","year":"2001","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jtemb.2010.01.006_bib50","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtemb.2010.01.006_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0003-2670(99)00074-4","article-title":"Investigation of metallodrug\u2013protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS)","volume":"387","author":"Szpunar","year":"1999","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.jtemb.2010.01.006_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.chroma.2005.09.042","article-title":"Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques","volume":"1106","author":"Huang","year":"2006","journal-title":"J Chromatogr A"},{"issue":"9","key":"10.1016\/j.jtemb.2010.01.006_bib53","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1039\/b822857d","article-title":"Comparison of two CE\u2013ICP-MS interfaces and quantitative measurements of carboplatin in plasma samples using an internal standard","volume":"24","author":"Moller","year":"2009","journal-title":"J Analyt Atom Spectrom"},{"issue":"2","key":"10.1016\/j.jtemb.2010.01.006_bib54","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.talanta.2006.12.012","article-title":"Speciation analysis of platinum antitumoral drugs in impacted tissues","volume":"72","author":"Esteban-Fern\u00e1ndez","year":"2007","journal-title":"Talanta"},{"key":"10.1016\/j.jtemb.2010.01.006_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1155\/MBD.1997.97","article-title":"Determination of biotransformation products of platinum drugs in rat and human urine","volume":"4","author":"Tang","year":"1997","journal-title":"Met Based Drugs"},{"key":"10.1016\/j.jtemb.2010.01.006_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/B708541A","article-title":"Species specific IDMS for accurate quantification of carboplatin in urine by LC\u2013ESI-TOFMS and LC\u2013ICP-QMS","volume":"23","author":"Koellensperger","year":"2008","journal-title":"J Anal Atom Spectrom"},{"key":"10.1016\/j.jtemb.2010.01.006_bib57","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.chemosphere.2007.05.062","article-title":"Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents","volume":"69","author":"Lenz","year":"2007","journal-title":"Chemosphere"},{"key":"10.1016\/j.jtemb.2010.01.006_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00216-004-2839-z","article-title":"Novel separation method for highly sensitive speciation of cancerostatic platinum compounds by HPLC\u2013ICP-MS","volume":"381","author":"Hann","year":"2005","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jtemb.2010.01.006_bib59","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1039\/b302241b","article-title":"Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC\u2013ICP-MS","volume":"18","author":"Vacchina","year":"2003","journal-title":"J Anal Atom Spectrom"}],"container-title":["Journal of Trace Elements in Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X10000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0946672X10000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T14:18:11Z","timestamp":1558793891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0946672X10000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0946672X10000076"],"URL":"https:\/\/doi.org\/10.1016\/j.jtemb.2010.01.006","relation":{},"ISSN":["0946-672X"],"issn-type":[{"value":"0946-672X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}